Long-term follow up of patients with human immunodeficiency virus infection and advanced stage Hodgkin's lymphoma treated with doxorubicin, bleomycin, vinblastine and dacarbazine

被引：7
|
作者：
Xicoy, Blanca [1 ]
Miralles, Pilar [2 ]
Morgades, Mireia [1 ]
Rubio, Rafael [3 ]
Valencia, Maria-Eulalia [4 ]
Ribera, Josep-Maria [1 ]
机构：
[1] Univ Autonoma Barcelona, ICO Hosp Germans Trias Pujol, Jose Carreras Leukemia Res Inst, Dept Clin Hematol, Badalona, Spain
[2] Hosp Gregorio Maranon, Dept Infect Dis, Madrid, Spain
[3] Hosp 12 Octubre, Dept Infect Dis, E-28041 Madrid, Spain
[4] Hosp Carlos III, Dept Infect Dis, Madrid, Spain
来源：
HAEMATOLOGICA | 2013年 / 98卷 / 08期
关键词：
Hodgkin's lymphoma; HIV-related; long-term follow up; opportunistic infections; second cancers; ACTIVE ANTIRETROVIRAL THERAPY; IMPACT; REGIMEN; HAART;
D O I：
10.3324/haematol.2012.079921
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E85 / E86
页数：2
相关论文
共 50 条
  • [21] Balancing Risks and Benefits of Therapy for Patients with Favorable-Risk Limited-Stage Hodgkin Lymphoma: The Role of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Chemotherapy Alone
    Hay, Annette E.
    Meyer, Ralph M.
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2014, 28 (01) : 49 - +
  • [22] Long-Term Follow-Up of Brentuximab Vedotin +/- Dacarbazine as First-Line Therapy in Elderly Patients With Hodgkin Lymphoma
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (08) : 18 - 19
  • [23] LONG-TERM FOLLOW-UP OF ADVANCED HODGKINS-DISEASE PATIENTS TREATED WITH A COMBINATION OF STREPTOZOTOCIN, LOMUSTINE (CCNU), DOXORUBICIN AND BLEOMYCIN (SCAB)
    WIERNIK, PH
    SCHIFFER, CA
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 1988, 114 (01) : 105 - 107
  • [24] Long-term follow-up of brentuximab vedotin ± dacarbazine as first line therapy in elderly patients with Hodgkin lymphoma.
    Friedberg, Jonathan W.
    Forero-Torres, Andres
    Holkova, Beata
    Goldschmidt, Jerome H.
    Boccia, Ralph V.
    Bordoni, Rodolfo
    Cline, Vivian Jean M.
    Patel-Donnelly, Dipti
    Flynn, Patrick J.
    Olsen, Gregg A.
    Chen, Robert W.
    Galderisi, Faith
    Wang, Yinghui
    Sharman, Jeff Porter
    Yasenchak, Christopher A.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [25] A successful initiation of treatment of Hodgkin's lymphoma with adriamycin-bleomycin-vinblastine-dacarbazine dose reduction in a patient with fulminant hepatic failure and co-infection with human immunodeficiency virus and hepatitis B
    Veeraballi, Sindhusha
    Chan, Kok H.
    Slim, Jihad
    Shaaban, Hamid S.
    Guron, Gunwant
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (02) : 479 - 485
  • [26] Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphoma
    Spicer, J
    Smith, P
    Maclennan, K
    Hoskin, P
    Hancock, B
    Linch, D
    Pettengell, R
    BRITISH JOURNAL OF CANCER, 2004, 90 (06) : 1151 - 1155
  • [27] Long-term follow-up of patients treated with radiotherapy alone for early-stage histologically aggressive non-Hodgkin's lymphoma
    J Spicer
    P Smith
    K Maclennan
    P Hoskin
    B Hancock
    D Linch
    R Pettengell
    British Journal of Cancer, 2004, 90 : 1151 - 1155
  • [28] Long-Term Follow-up of Survival in Hodgkin's Lymphoma.
    Canellos, George P.
    Niedzwiecki, Donna
    Johnson, Jeffrey L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (24): : 2390 - 2391
  • [29] An unmet need for long-term follow-up in Hodgkin's lymphoma?
    Gisselbrecht, Christian
    LANCET HAEMATOLOGY, 2018, 5 (10): : E435 - E436
  • [30] Prognostic factors of advanced Hodgkin's lymphoma: multivariate analysis of 199 Chinese patients with long-term follow-up.
    Wang, Qin
    Qin, Yan
    Kang, Suyi
    He, Xiaohui
    Liu, Peng
    Yang, Sheng
    Zhou, Shengyu
    Zhang, Changgong
    Gui, Lin
    Yang, Jianliang
    Sun, Yan
    Shi, Yuankai
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345